A detailed history of Xtx Topco LTD transactions in Bio Atla, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 164,367 shares of BCAB stock, worth $225,182. This represents 0.08% of its overall portfolio holdings.

Number of Shares
164,367
Holding current value
$225,182
% of portfolio
0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.88 - $3.46 $309,009 - $568,709
164,367 New
164,367 $565,000
Q3 2023

Nov 13, 2023

SELL
$1.7 - $3.07 $124,985 - $225,709
-73,521 Reduced 66.53%
36,991 $62,000
Q2 2023

Aug 14, 2023

BUY
$2.83 - $3.87 $312,748 - $427,681
110,512 New
110,512 $331,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $5.38 $40,691 - $102,779
19,104 Added 105.31%
37,244 $106,000
Q1 2022

May 13, 2022

BUY
$4.38 - $18.78 $79,453 - $340,669
18,140 New
18,140 $91,000

Others Institutions Holding BCAB

About BioAtla, Inc.


  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $49.7M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.